Retrograde Ascending Dissection: Intraluminal Aortic Therapy

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 149 participants.

Also called NCT07405242

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 149 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07405242
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07405242. Allocation not applicable; no masking; primary purpose treatment. Start 2026-01-01 (actual); primary completion 2029-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Retrograde Ascending Dissection: Intraluminal Aortic Therapy
Acronym
RADIAL
Condition
Ascending Aortic Dissection
Intervention (Device)
Endovascular treatment of aortic dissection (stent implantation)
Lead sponsor
Ruijin Hospital (class: other)

Record details

Record id
cardio:ct-nct07405242
Content hash
1cddbf162004cc8a6668d939e57c5c80b3988f348d79db931d9b83320b1fc906